Comments
Loading...

Contineum Therapeutics

CTNMNASDAQ
Logo brought to you by Benzinga Data
$14.09
-0.25-1.74%
At close: -
$14.80
0.715.04%
After Hours: Nov 22, 8:59 AM EDT

Contineum Therapeutics (NASDAQ:CTNM) Stock, Earnings Estimates, EPS, And Revenue

Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 16
EPS Estimate
$-0.430
Quarterly Revenue Estimate
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Contineum Therapeutics (CTNM) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-06$-0.40$-0.436.98 %
Jun 20242024-08-13$-0.39$-0.35-11.4 %

Contineum Therapeutics (CTNM) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?

A

Contineum Therapeutics (CTNM) is scheduled to report earnings on February 16, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?

A

The Actual EPS was $-0.40, which beat the estimate of $-0.43.

Q

What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch